2019, Number 1
<< Back Next >>
Rev Mex Ortodon 2019; 7 (1)
Effects of micro-vibration at 30 Hz on IL-17 and RANKL expression in in vitro mouse skull-derived osteoblasts and bone marrow-derived osteoclasts
García LS, Villanueva ARE, Pérez VJL, Juárez NLI, Paéz Arenas A, Massó LF, Meikle MC
Language: Spanish
References: 27
Page: 24-32
PDF size: 240.50 Kb.
ABSTRACT
Introduction: Micro-vibration therapy in patients with osteoporosis has been shown to induce remodeling in the outer cortical bone perhaps due to inhibition of the osteoclastic activity.
Objective: We assessed the effects of exposure to micro-vibration for 20 minutes at 30 Hz in osteoblastic and osteoclastic cells to determine the expression of IL-17 and RANKL. Material and methods: Osteoblasts derived from the skull and osteoclasts derived from tibia stem cells of a Balb/c strain mouse were cultured in 24-well plates (Gybco, USA) in the following culture media, respectively: DMEM F-12 (ATCC, USA) and α-MEM (ATCC, USA), adding 0.5
µL/mL of 1α, 25-Dihydroxivitamin D
3 (Sigma-Aldrich, USA) to the latter. Both culture media were supplemented with 10% fetal bovine serum (Gybco, USA), 1% of antibiotics and antifungals. Incubation (NuAire, USA) was done in an atmosphere of 5% CO
2, 95% humidity at 37 oC. Cultured cells were subsequently subjected to micro-vibrations (0.25 N, 30 Hz) with AcceleDent (Ortho Accel, USA) for 20 minutes. Before and after exposure to the vibrations 500
µL of supernatant of both cultured cells were collected and stored in an ultra-low temperature freezer at -70
oC (Thermo, USA) to later determine IL-17 and RANKL expression (Peprotech, Rocky Hill, NJ, USA) by ELISA test.
Results: Micro-vibration produced a statistically significant upregulation of IL-17 and downregulation of RANKL in both cultured osteoblasts and osteoclasts in the experimental group compared with the control group.
Conclusion: Micro-vibration at 30 Hz for 20 minutes applied to
in vitro cultures of osteoblastic and osteoclastic cells produces soluble factors related to osteoclastic maturation and inhibition.
REFERENCES
García-López S, Meikle MC, Villanueva RE, Montaño L, Massó F, Ramírez-Amador V et al. Mechanical deformation inhibits IL-10 and stimulates IL-12 production by mouse calvarial osteoblasts in vitro. Arch Oral Biol. 2005; 50: 449-452.
García-López S, Villanueva R, Meikle MC. Alterations in the synthesis of IL-1β, TNF-α, IL-6, and their downstream targets RANKL and OPG by mouse calvarial osteoblasts in vitro: Inhibition of bone resorption by cyclic mechanical strain. Front Endocrinol. 2013; 4: 160. doi:10.3389/fendo.2013.00160.
García-López S, Villanueva R, Juárez L, Pérez J. Evaluación de la microvibración en osteoblastos y osteoclastos cultivados in vitro sobre la producción de IL-4 e IL-13 con el uso del AcceleDent. Ortodoncia Actual. 2017; 13 (54): 42-45.
Garman R, Gaudette G, Donahue LR, Rubin C, Judex S. Low level accelerations applied in the absence of weight bearing can enhance trabecular bone formation. J Orthop Res. 2007; 25 (6): 732-740.
Xie L, Jacobson JM, Choi ES, Busa B, Donahue LR, Miller LM et al. Low-level mechanical vibrations can influence bone resorption and bone formation in the growing skeleton. Bone. 2006; 39 (5): 1059-1066.
Rath B, Nam J, Knobloch TJ, Lannutti JJ, Agarwal S. Compressive forces induce osteogenic gene expression in calvarial osteoblasts. J Biomech. 2008; 41 (5): 1095-1103.
Tanaka SM, Li J, Duncan RL, Yokota H, Burr DB, Turner CH. Effects of broad frequency vibration on cultured osteoblasts. J Biomech. 2003; 36 (1): 73-80.
Rath B, Nam J, Knobloch TJ, Lannutti JJ, Agarwal S. Compressive forces induce osteogenic gene expression in calvarial osteoblasts. J Biomech. 2008; 41 (5): 1095-1103.
Rubin C, Turner AS, Müller R, Mittra E, McLeod K, Lin W, Qin Y. Quantity and quality of trabecular bone in the femur are enhanced by a strongly anabolic, noninvasive mechanical intervention. J Bone Miner Res. 2002; 17 (2): 349-357.
Xie L, Jacobson JM, Choi ES, Busa B, Donahue LR, Miller LM et al. Low-level mechanical vibrations can influence bone resorption and bone formation in the growing skeleton. Bone. 2006; 39 (5): 1059-1066.
Rubin J, Murphy TC, Fan X, Goldschmidt M, Taylor WR. Activation of extracellular Signal-Regulated kinase is involved in mechanical strain inhibition of RANKL expression in bone stromal cells. J Bone Miner Res. 2002; 17 (8): 1452-1460.
Alikhani M, Khoo E, Alyami B, Raptis M, Salgueiro JM, Oliveira SM et al. Osteogenic effect of high-frequency acceleration on alveolar bone. J Dent Res. 2012; 91 (4): 413-419.
Yadav S, Assefnia A, Gupta H, Vishwanath M, Kalajzic Z, Allareddy V et al. The effect of low-frequency mechanical vibration on retention in an orthodontic relapse model. Eur J Orthod. 2016; 38 (1): 44-50.
Heath JK, Saklatvala J, Meikle MC, Atkinson SJ, Reynolds JJ. Pig interleukin 1 (catabolin) is a potent stimulator of bone resorption in vitro. Calcif Tissue Int. 1985; 37: 95-97.
Tumber A, Papaioannou J, Breckon JJW, Meikle MC, Reynolds JJ, Hill PA. The effects of serine proteinase inhibitors on bone resorption in vitro. J Endocrinol. 2003; 178: 437-447.
Bezerra MC, Carvalho JF, Prokopowitsch AS, Pereira RM. RANK, RANKL and osteoprotegerin in arthritic bone loss. Braz J Med Biol Res. 2005; 38: 161-170.
Koenders MI, Kolls JK, Oppers-Walgreen B, van den Bersselaar L, Joosten LA, Schurr JR et al. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis. Arthritis Rheum. 2005; 52 (10): 3239-3247.
Zhang F, Koyama Y, Sanuki R, Mitsui N, Suzuki N, Kimura A et al. IL-17A stimulates the expression of inflammatory cytokines via celecoxibblocked prostaglandin in MC3T3-E1 cells. Arch Oral Biol. 2010; 55: 679-688.
Kuwabara A, Tanabe N, Kawato T, Tanaka H, Nakai K, Iinuma T et al. Interleukin17A induces extracellular matrix protein expression in osteoblastic ROS17/2.8 cells. J Hard Tissue Biol. 2011; 20: 247-258.
Nakashima T, Takayanagi H. Osteoimmunology: crosstalk between the immune and bone systems. J Clin Immunol. 2009; 29: 555-567.
Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998; 93: 165-176.
Vega D, Maalouf NM, Sakhaee K. The role of receptor activator of nuclear factor-κB (RANK)/RANK ligand/osteoprotegerin: Clinical implications. J Clin Endocrinol Metab. 2007; 92: 4514-4521.
Kitami S, Tanaka H, Kawato T, Tanabe N, Katono-Tani T, Zhang F et al. IL-17A suppresses the expression of bone resorption-related proteinases and osteoclast differentiation via IL-17RA or IL-17RC receptors in RAW264.7 cells. Biochimie. 2010; 92: 398-404.
Fujisaki K, Tanabe N, Suzuki N, Kawato T, Takeichi O, Tsuzukibashi O et al. Receptor activator of NF-κB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9
in osteoclast precursor RAW264.7 cells. Life Sci. 2007; 80: 1311-1318.
Suzuki N, Kitamura K, Nemoto T et al. Effect of vibration on osteoblastic and osteoclastic activities: analysis of bone metabolism using goldfish scale as a model for bone. Adv Space Res. 2007; 40: 1711-1721.
Wu SH, Zhong ZM, Chen JT. Low-magnitude high-frequency vibration inhibits RANKL-induced osteoclast differentiation of RAW264.7 cells. Int J Med Sci. 2012; 9: 801-807.
Kalajzic Z, Peluso EB, Utreja A, Dyment N, Nihara J, Xu M et al. Effect of cyclical forces on the periodontal ligament and alveolar bone remodeling during orthodontic tooth movement. Angle Orthod. 2014; 84 (2): 297-303.